Terrance McGuire
CIK 1117003 · last filed 2026-07-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TTGT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1000 WINTER STREET, SUITE 3350
WALTHAM, MA 02154
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEER | Director | 343,636 | $2.00 | $685.6K | $1.50M | 9 | 2026-07-30 |
| IVVD | Director | 3,170,231 | $0.59 | $1.87M | -$1.02M | 10 | 2026-05-21 |
| TECX | Director | 20,262 | $20.16 | $408.5K | -$8.55M | 2 | 2025-06-11 |
| Cyclerion Therapeutics, Inc. (CYCN) Delisted | Director | 842 | $23.52 | $19.8K | $10.32M | 9 | 2023-12-04 |
| ALEC | Director | 10,908,813 | $2.04 | $22.20M | -$3.14M | 11 | 2023-09-13 |
| Invivyd, Inc. (ADGI) Delisted | Director | 31,198 | $4.64 | $144.8K | $8.50M | 4 | 2022-06-24 |
| PULM | Director | — | $1.46 | — | $0 | 5 | 2019-05-20 |
| IRWD | Director | 142,747 | $3.48 | $496.8K | -$19.0K | 35 | 2019-04-03 |
| IRONWOOD PHARMACEUTICALS INC (IRWDV) Delisted | Director | 146,803 | — | — | $0 | 1 | 2019-03-19 |
| X4 Pharmaceuticals, Inc (ASNS) Delisted | Director | 1 | $0.08 | $0 | $5.00M | 4 | 2018-06-07 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 1,250 | $178.75 | $223.4K | -$25.72M | 18 | 2017-03-14 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 4,278 | $5.54 | $23.7K | -$1.21M | 2 | 2013-06-19 |
| TTGT | 10%+ Owner | 31,629 | $3.58 | $113.1K | -$240.00M | 1 | 2010-12-10 |
| DECODE GENETICS INC (DCGN) Delisted | Director | 117,516 | — | — | $0 | 3 | 2008-12-16 |
Recent Filings · Page 11 of 12
117 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-09-26 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | +3,121,164 | $0 | EDGAR |
| 2013-08-16 | IRWD | Other (J) | +383 | $0 | EDGAR |
| 2013-08-01 | IRWD | Other (J) | +383 | $0 | EDGAR |
| 2013-06-19 | ALIMERA SCIENCES INC (ALIM) Delisted | Sell (S) | −222,378 | -$1.21M | EDGAR |
| 2013-06-17 | IRWD | Other (J) | +383 | $0 | EDGAR |
| 2013-06-05 | IRWD | Other (J) | +383 | $0 | EDGAR |
| 2012-12-05 | IRWD | Other (J) | +390 | $0 | EDGAR |
| 2012-11-19 | IRWD | Other (J) | +383 | $0 | EDGAR |
| 2012-09-17 | IRWD | Other (J) | +383 | $0 | EDGAR |
| 2011-12-07 | IRWD | Other (J) | +384 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.